← BANK5 2026-5YR20 · Loan annex · CMBS market
- Deal
- BANK5 2026-5YR20
- Current balance
- $42.0M (September 2026)
- Share of deal
- 4.4%
- Status
- Current
- DSCR (latest)
- not yet reported
- Occupancy (latest)
- not yet reported
- Scheduled maturity
- 2036-01-09
Property and terms
| Property | TORREY HEIGHTS |
| Address | 11202-11214 EL CAMINO REAL; San Diego, CA 92130 |
| Property type | Mixed use |
| Units, beds or keys | not yet reported |
| Net rentable square feet | 520,604 |
| Year built | 2023 |
| Year last renovated | not yet reported |
| Original balance | $42.0M |
| Current balance | $42.0M (September 2026) |
| Share of deal balance | 4.4% |
| Interest rate at origination | 4.97% |
| Current interest rate | 4.97% |
| Origination date | 01-09-2026 |
| Original term | 60 months |
| Amortization term | not yet reported |
| Interest-only period | 60 months |
| Scheduled maturity | 2036-01-09 |
| Prepayment lockout end | 07-08-2030 |
| Yield maintenance end | not yet reported |
| Servicer | Trimont LLC |
| Loan servicer | not yet reported |
| Originator | JPMorgan Chase Bank, National Association |
| Current status | Current |
| Specially serviced now | No |
| Defeased | No |
Valuation
| Basis | Amount | Date | Source (as filed) |
|---|---|---|---|
| At securitization | $723.4M | 01-05-2026 | MAI |
Largest tenants
| Tenant | Square feet | Lease expiration |
|---|---|---|
| Pfizer Inc. | 230,132 | 03-30-2039 |
| Becton Dickinson and Company | 220,270 | 07-31-2036 |
| Architect Therapeutics inc | 29,734 | 09-30-2031 |
The three largest tenants as reported in the latest asset-level record.
Monthly history
| Month | Balance | Status | Rate | DSCR (NCF) | DSCR (NOI) | Occupancy | Advances | Financial period end | Revenue | Expenses | NOI | NCF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| February 2026 | $42.0M | Current | 4.97% | 0.49 | 0.49 | 100% | $0 | 10-31-2025 | $23.3M | $14.2M | $9.1M | $9.1M |
| March 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| April 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| May 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| June 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| July 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| August 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| September 2026 | $42.0M | Current | 4.97% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
Revenue, expenses, net operating income (NOI) and net cash flow (NCF) are the most recent financials reported as of each month, for the financial period ending on the date shown. DSCR is debt service coverage on the net cash flow and net operating income bases as reported.
Also filed in other trusts
Loans are sometimes split across trusts (pari passu), and each trust files the loan at its whole-loan amount. A loan with the same property name and origination date is filed in: BANK5 2026-5YR21; Benchmark 2026-V20 Mortgage Trust; Benchmark 2026-V21 Mortgage Trust; Benchmark 2026-V21 Mortgage Trust; Benchmark 2026-V21 Mortgage Trust.
Sources: SEC Form ABS-EE asset-level reports for the deal. Definitions are in the methods note on the market page.